Dongkook, KR7086450004

Dongkook stock gained 2.71 percent after IBK coverage

Published on 10/04/2026 at 18:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Dongkook stock reached KRW 22,750 on October 2, 2026, while Q2 revenue rose 10.9 percent year over year. IBK set a KRW 30,000 target after initiating coverage.

Dongkook, KR7086450004, Illustration mit AI erstellt.
Dongkook, KR7086450004, Illustration mit AI erstellt.

Dongkook stock was last at KRW 22,750 on the KOSDAQ on October 2, 2026 at 3:30 p.m. KST, up KRW 600 or 2.71 percent from the prior close. The move followed new analyst coverage focused on the pharmaceutical companys cosmetics expansion and overseas distribution.

IBK starts coverage at Buy

EDAILY reported on October 2, 2026 that IBK Investment & Securities initiated coverage with a Buy rating and a KRW 30,000 target price. The target stands KRW 7,250 above the October 2 price, equal to 31.9 percent above the price.

IBK projected second-half 2026 revenue of KRW 547.5 billion, up 16.6 percent year over year, and operating profit of KRW 60.1 billion, up 22.5 percent. The brokerage linked the forecast to wider overseas distribution for Dongkooks Centellian24 cosmetics business.

Revenue growth meets margin pressure

Dongkook reported Q2 2026 revenue of KRW 258.9 billion, up 10.9 percent year over year, and operating profit of KRW 26.1 billion, giving the quarter a 10.1 percent operating margin, according to ATS View. Net income was KRW 17.2 billion, compared with KRW 26.3 billion in Q1 2026, making profitability the key counterweight to the sales trend.

The same Q2 data show revenue of KRW 258.9 billion versus KRW 251.0 billion in Q1, while operating profit declined from KRW 27.3 billion to KRW 26.1 billion. For investors, the overseas cosmetics ramp therefore has to translate into operating leverage rather than revenue growth alone.

Consensus target remains higher

Investing.com lists a Strong Buy consensus based on 1 analyst, with an average, high and low 12-month target of KRW 30,000. The consensus target is KRW 7,250 above the October 2 price, or 31.9 percent above it.

Dongkook stock holds above KRW 22,000

Dongkook stock was last at KRW 22,750 on the KOSDAQ on October 2, 2026. Its 52-week range was KRW 16,260 to KRW 31,250, while market capitalization stood at KRW 1.0 trillion and trading volume reached 762,868 shares.

Dongkook stock details

  • Company: DongKook Pharmaceutical Co., Ltd.
  • ISIN: KR7086450004
  • Ticker: 086450
  • Trading venue: KOSDAQ
  • Price (as of October 2, 2026, 3:30 p.m. KST): KRW 22,750
  • Market capitalization: KRW 1.0 trillion (as of October 2, 2026)
  • 52-week range: KRW 16,260-31,250 (as of October 2, 2026)
  • Sector / Industry: Pharmaceuticals

More news and analyses on Dongkook stock

Disclaimer...

en | KR7086450004 | DONGKOOK | boerse | 70227299 | bgmi